Cardiac biomarkers play a pivotal role in modern healthcare, providing valuable insights into the functioning of the heart and aiding in the diagnosis, prognosis, and monitoring of cardiovascular conditions. These biomarkers, often proteins released into the bloodstream in response to heart damage or stress, serve as crucial indicators for healthcare professionals. Troponins, creatine kinase-MB (CK-MB), and B-type natriuretic peptide (BNP) are among the well-known cardiac biomarkers. The detection and analysis of these biomarkers have significantly enhanced our ability to assess cardiac health, allowing for early intervention and personalized treatment strategies. As the field of cardiac biomarkers continues to evolve, ongoing research explores novel markers and advanced diagnostic technologies, promising further advancements in cardiovascular care. The comprehensive understanding of cardiac biomarkers contributes to more accurate diagnoses, improved patient outcomes, and a deeper comprehension of heart-related diseases.
Title : Pharmacological advancement in pulmonary arterial hypertension treatment - Contribution of treprostinil dry-powder formulation
Miroslav Radenkovic, University of Belgrade, Serbia
Title : Historical evolution from OPCAB to MIDCAB to mini OPCAB surgical technique and results
Federico Benetti, Benetti Foundation, Argentina
Title : Personalized and Precision Medicine (PPM) and PPN-guided cardiology practice as a unique model via translational applications and upgraded business modeling to secure human healthcare, wellness and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibodies with functionality as a new generation of translational tools designed to monitor autoimmune myocarditis at clinical and subclinical stages
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation